Site Search
Professionals 2 results
Capabilities 1 result
Industry
Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations.
Insights & News 1 result
News
|May 13, 2011
|Less Than 1 Min Read
Winston Prevails in Patent Trial for Teva Pharmaceuticals
Winston & Strawn recently prevailed in a patent trial for client Teva Pharmaceuticals. In 2009, Teva filed an Abbreviated New Drug Application seeking FDA approval to make and sell a generic version of Amrix, a brand drug prescribed to treat muscle spasms. The patent holder sued Teva for infringement of two patents covering Amrix. After a bench trial before Judge Sue Robinson in the District of Delaware in October 2010, Judge Robinson issued a ruling finding both patents invalid for obviousness. The ruling opens the door for generic companies to provide patients with a much lower cost alternative to Amrix.